Cipla Technologies, Pulmatrix agree for development and commercialization of Pulmazole
Cipla shall now have exclusive rights for the development and commercialisation of Pulmazole in all countries except the United States of America
Cipla shall now have exclusive rights for the development and commercialisation of Pulmazole in all countries except the United States of America
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
US FDA approval based on NEURO-TTRansform Phase III results
World HRD Congress is a well-known international body of Management Studies
Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients
His resignation would be effective from March 18, 2024
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Subscribe To Our Newsletter & Stay Updated